Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 57 points (-0.3%) at 18,059 as of Friday, June 19, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,336 issues advancing vs. 1,624 declining with 175 unchanged. The Health Care sector currently sits down 0.2% versus the S&P 500, which is down 0.3%. Top gainers within the sector include HCA Holdings ( HCA), up 1.7%, Bristol-Myers Squibb Company ( BMY), up 1.0%, AbbVie ( ABBV), up 0.9%, Amgen ( AMGN), up 0.8% and CVS Health ( CVS), up 0.6%. On the negative front, top decliners within the sector include Biomarin Pharmaceutical ( BMRN), down 1.5%, Novo Nordisk A/S ( NVO), down 1.3%, Merck ( MRK), down 0.8% and Gilead ( GILD), down 0.6%. TheStreet would like to highlight 3 stocks pushing the sector higher today: 3. Baxter International ( BAX) is one of the companies pushing the Health Care sector higher today. As of noon trading, Baxter International is up $0.51 (0.7%) to $69.76 on heavy volume. Thus far, 3.1 million shares of Baxter International exchanged hands as compared to its average daily volume of 4.1 million shares. The stock has ranged in price between $69.01-$69.94 after having opened the day at $69.32 as compared to the previous trading day's close of $69.25. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. Baxter International Inc., develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $37.1 billion and is part of the health services industry. Shares are down 7.0% year-to-date as of the close of trading on Thursday. Currently there are 3 analysts who rate Baxter International a buy, 1 analyst rates it a sell, and 9 rate it a hold. TheStreet Ratings rates Baxter International as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, reasonable valuation levels and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, generally higher debt management risk and weak operating cash flow. Get the full Baxter International Ratings Report now. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.